GPS Wealth Strategies Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Sell |
|
|||||
|
2025
Q1 | $367K | Hold |
|
|||||
|
2024
Q4 | $227K | Buy |
|
|||||
|
2024
Q3 | $180K | Buy |
|
|||||
|
2024
Q2 | $140K | Hold |
|
|||||
|
2024
Q1 | $137K | Hold |
|
|||||
|
2023
Q4 | $146K | Sell |
|
|||||
|
2023
Q3 | $119K | Hold |
|
|||||
|
2023
Q2 | $168K | Hold |
|
|||||
|
2023
Q1 | $104K | Hold |
|
|||||
|
2022
Q4 | $85.2K | Sell |
|
|||||
|
2022
Q3 | $101K | Hold |
|
|||||
|
2022
Q2 | $100K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $173K | Buy |
|
|||||
|
2021
Q3 | $142K | Buy |
|
|||||
|
2021
Q2 | $200K | Buy |
|
|||||
|
2021
Q1 | $212K | Buy |
|
|||||
|
2020
Q4 | $226K | Buy |
|
|||||
|
2020
Q3 | $270K | Buy |
|